Omrix, a commercial-stage biopharmaceutical company, develops and markets innovative biosurgical and passive immunotherapy products, utilizing its proprietary protein purification technology and manufacturing know-how. As part of its business strategy, Omrix commercializes certain of its biosurgical products through collaborations with companies whose marketing and sales expertise are a complement to Omrix''s own areas of specialty. Omrix''s novel and easy-to-use biological-device convergence products address unmet medical needs.